Fevertree share price: where next after UK sales slump
The premium producer of carbonated mixers saw its share price slide after a disappointing set of full-year results highlighted the potential pitfalls of premiumisation.
Fevertree shares have fallen more than 30% since the beginning of January, with its full-year (FY) results last week highlighting the pitfalls of its premiumisation strategy, with UK sales shrinking 1% to £132.6 million in 2019 after Christmas trading was ‘subdued’.
However, weak UK sales were offset by strong revenue growth in the US and Europe, with the two markets expanding by 33% and 16% respectively. As such, group revenue is expected to hit £260.6 million, representing growth of around 10%, though this is below the company’s own guidance.
‘Despite the subdued end to the year in the UK, we have delivered a strong performance across many of our regions in 2019 and begin 2020 with real momentum in a number of key growth markets,’ Fevertree chief executive officer (CEO) Time Warrillow said.
‘Whilst the UK mixer category has clearly not been immune from the consumer belt tightening seen in recent months, we remain the clear category leader and have a strong platform to return to growth during 2020 and beyond,’ he added.
‘Fever-Tree is the No.1 premium mixer globally and our performance in 2019 across US, Europe and as far afield as Australia and Canada highlights the fast-growing international strength of the business.’
Ready to start hedging? Open an account with IG today to get started.
Analysts downgrade Fevertree share price outlook
Several analysts including Deutsche Bank, JP Morgan Cazenove, Jefferies and RBC Capital Markets downgraded their price target for the stock in January.
RBC Capital Markets offered the dimmest outlook for Fevertree in 2020, with its analysts downgrading its target price to £13 a share.
Based on the stock trading at £14.45 a share as of 12:30 (GMT) on Tuesday, RBC Capital Markets believes the stock has a potential downside of -10%.
Do you own Fevertree shares? You can hedge your downside risk by trading CFDs.
This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only
